The Yellow Card Scheme, run by the UK's MHRA since 1964, is a voluntary system for reporting suspected adverse drug reactions (ADRs) from medicines, vaccines, devices, and more—anyone can submit, but there's no formal "enforcement" mechanism.rdtc+1
Healthcare professionals and patients report suspicions (no proof needed) online at yellowcard.mhra.gov.uk, via app, or paper forms, prioritizing serious cases, black triangle (new) drugs, children, elderly, or off-label use. MHRA analyzes data for signals like label changes or withdrawals, but reporting is not mandatory except for certain professionals under legal duties.yellowcard.mhra+2
Reports have led to safety updates (e.g., dopamine agonist warnings), but the scheme relies on vigilance—under-reporting is common, with no penalties for non-reporting unless negligence is proven in court. For your dopamine agonist advocacy, encourage victims to file Yellow Cards to build evidence for accountability.gov+1
Dopamine Justice Alliance